Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 23762954)

1.

ML302, a Novel Beta-lactamase (BLA) Inhibitor.

Spicer T, Minond D, Enogieru I, Saldanha SA, Allais C, Liu Q, Mercer BA, Roush WR, Hodder P.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2012 Apr 16 [updated 2014 May 13].

2.

HTS Assay for Discovery of Novel Metallo-Beta-lactamase (MBL) Inhibitors.

Minond D, Saldanha SA, Spicer T, Qin L, Mercer BA, Roush WR, Hodder P.

Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010-.
2009 Nov 13 [updated 2011 May 5].

3.

Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries.

Minond D, Saldanha SA, Subramaniam P, Spaargaren M, Spicer T, Fotsing JR, Weide T, Fokin VV, Sharpless KB, Galleni M, Bebrone C, Lassaux P, Hodder P.

Bioorg Med Chem. 2009 Jul 15;17(14):5027-37. doi: 10.1016/j.bmc.2009.05.070. Epub 2009 Jun 22.

4.

Metallo-beta-lactamase-producing imipenem-resistant Pseudomonas aeruginosa clinical isolates in a university teaching hospital in Malaysia: detection of IMP-7 and first identification of IMP-4, VIM-2, and VIM-11.

Khosravi Y, Tee Tay S, Vadivelu J.

Diagn Microbiol Infect Dis. 2010 Jul;67(3):294-6. doi: 10.1016/j.diagmicrobio.2010.02.010. Epub 2010 May 11.

PMID:
20462725
5.

bla(IMP) and bla(VIM) mediated carbapenem resistance in Pseudomonas and Acinetobacter species in India.

Amudhan MS, Sekar U, Kamalanathan A, Balaraman S.

J Infect Dev Ctries. 2012 Nov 26;6(11):757-62. doi: 10.3855/jidc.2268.

6.

Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France.

Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo JD, Nordmann P.

Antimicrob Agents Chemother. 2000 Apr;44(4):891-7.

7.

Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.

Ozgumus OB, Caylan R, Tosun I, Sandalli C, Aydin K, Koksal I.

Microb Drug Resist. 2007 Fall;13(3):191-8.

PMID:
17949306
8.
9.

Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.

Sader HS, Castanheira M, Mendes RE, Toleman M, Walsh TR, Jones RN.

Int J Antimicrob Agents. 2005 Jan;25(1):57-61.

PMID:
15620827
10.

Identification and distribution of the clinical isolates of imipenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase and/or class 1 integron genes.

Cheng X, Wang P, Wang Y, Zhang H, Tao C, Yang W, Liu M, Jia W.

J Huazhong Univ Sci Technolog Med Sci. 2008 Jun;28(3):235-8. doi: 10.1007/s11596-008-0301-8. Epub 2008 Jun 19.

PMID:
18563313
11.

Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.

Juan C, Beceiro A, Gutiérrez O, Albertí S, Garau M, Pérez JL, Bou G, Oliver A.

Antimicrob Agents Chemother. 2008 Oct;52(10):3589-96. doi: 10.1128/AAC.00465-08. Epub 2008 Jul 21.

12.

Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme.

Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, Wu JJ.

Antimicrob Agents Chemother. 2001 Aug;45(8):2224-8.

13.

Antibiotic Resistance Pattern and Evaluation of Metallo-Beta Lactamase Genes Including bla- IMP and bla- VIM Types in Pseudomonas aeruginosa Isolated from Patients in Tehran Hospitals.

Aghamiri S, Amirmozafari N, Fallah Mehrabadi J, Fouladtan B, Samadi Kafil H.

ISRN Microbiol. 2014 Apr 23;2014:941507. doi: 10.1155/2014/941507. eCollection 2014.

14.

Occurrence of IMP-8, IMP-10, and IMP-13 metallo-β-lactamases located on class 1 integrons and other extended-spectrum β-lactamases in bacterial isolates from Tunisian rivers.

Chouchani C, Marrakchi R, Henriques I, Correia A.

Scand J Infect Dis. 2013 Feb;45(2):95-103. doi: 10.3109/00365548.2012.717712. Epub 2012 Sep 19.

PMID:
22992193
15.

Novel acquired metallo-beta-lactamase gene, bla(SIM-1), in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea.

Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, Rossolini GM, Chong Y.

Antimicrob Agents Chemother. 2005 Nov;49(11):4485-91.

16.

PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron.

Shibata N, Doi Y, Yamane K, Yagi T, Kurokawa H, Shibayama K, Kato H, Kai K, Arakawa Y.

J Clin Microbiol. 2003 Dec;41(12):5407-13.

17.

Antimicrobial resistance pattern and their beta-lactamase encoding genes among Pseudomonas aeruginosa strains isolated from cancer patients.

Zafer MM, Al-Agamy MH, El-Mahallawy HA, Amin MA, Ashour MS.

Biomed Res Int. 2014;2014:101635. doi: 10.1155/2014/101635. Epub 2014 Feb 23.

18.

Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.

Kouda S, Ohara M, Onodera M, Fujiue Y, Sasaki M, Kohara T, Kashiyama S, Hayashida S, Harino T, Tsuji T, Itaha H, Gotoh N, Matsubara A, Usui T, Sugai M.

J Antimicrob Chemother. 2009 Jul;64(1):46-51. doi: 10.1093/jac/dkp142. Epub 2009 Apr 27.

19.

Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.

Lin YC, Sheng WH, Chen YC, Chang SC, Hsia KC, Li SY.

Int J Antimicrob Agents. 2010 May;35(5):439-43. doi: 10.1016/j.ijantimicag.2009.11.020. Epub 2010 Jan 27.

PMID:
20106635
20.

An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases.

Pal A, Tripathi A.

Infect Genet Evol. 2013 Dec;20:39-47. doi: 10.1016/j.meegid.2013.07.028. Epub 2013 Aug 15.

PMID:
23954421
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk